🌿

Cannabidiol / CBD Oil

Cannabis sativa (CBD extract)

Anti-tumourmoderate evidence

CBD (cannabidiol) and other non-psychoactive cannabinoids show documented anti-tumour activity against breast, brain, colon, and lung cancers through CB1/CB2 receptor pathways, inducing apoptosis and inhibiting angiogenesis. CBD is widely used for cancer-related pain, nausea, anxiety, and sleep disturbance. THC additionally stimulates appetite in cancer cachexia. Dronabinol (synthetic THC) is FDA-approved for chemotherapy-induced nausea.

Medicinal Properties

Anti-tumourAnalgesicAnti-nauseaAnti-anxietyAppetite stimulating

🎗️

Cancer Types Studied

BreastBrainColonLungProstate

Recommended Dosage

5–100 mg CBD daily. Start low (5–10 mg) and titrate up.

Preparations

Full-Spectrum CBD Oil

5–100 mg full-spectrum CBD oil daily (sublingual). Start low, increase gradually. Full-spectrum preferred over isolate for entourage effect.

NIH / PubMed Research

PMID 22198381Cannabidiol anti-tumour mechanisms

Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.

Cautions & Interactions

Legal status varies by country — check local laws
Inhibits CYP3A4 and CYP2C19 — may affect chemo drug levels (discuss with oncologist)
THC legal only with prescription in most countries
Discuss all cannabis use with oncology team